Consistent with its metabolically unfavorable phenotype, asprosin is found pathologically elevated in individuals and rodent models with metabolic syndrome including obesity and type 2 diabetes in multiple studies [67, 68, 75–78]. The gene discussed is FBN1; the disease is obesity due to melanocortin 4 receptor deficiency.